A Study of CS1002 in Subjects with Advanced Solid Tumors

Clinical trial NCT03523819 · COMPLETED

Trial details

NCT number: NCT03523819
Sponsor: CStone Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2018-04-26
Primary completion: 2022-01-18
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.